Search

everythinglearnresearchcommunity

for

Search:↓

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The conclusion is that healthcare professionals should report adverse drug reactions to improve medication safety and patient care.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

Finasteride may reduce depression and anxiety in female rats and improve brain connectivity.

Tiny particles called anionic squarticles can effectively remove a common antidepressant from the body after an overdose.

Switching to extended-release divalproex sodium improved patient-reported tremor but did not change seizure frequency or most side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

Finasteride and dutasteride may increase the risk of depression and suicidality, so patients should be monitored closely.

Finasteride may cause depression and suicidal thoughts, especially in young men.

D-004 shows moderate antidepressant effects but is less effective than Sertraline and Imipramine.

Topical ruxolitinib quickly improves non-segmental vitiligo.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Levetiracetam often causes behavioral issues, while oxcarbazepine is more likely to cause sleepiness in epilepsy patients.

Enfortumab vedotin can cause skin issues, especially in older males, needing early monitoring.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Ozenoxacin reduces sebum production, helping manage acne.

Benzothiazepines like diltiazem reduce anxiety in mice by making neurosteroids.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

Bupropion SR may help treat trichotillomania.